Addressing Resistance in the Development of Cancer Immune Modulator Therapy

Mon Nov 14 2022 at 08:30 am to Tue Nov 15 2022 at 12:00 pm

NAS Building | Washington

NASEM Health and Medicine
Publisher/HostNASEM Health and Medicine
Advertisement
On November 14-15, the National Academies will host a hybrid workshop on immune modulator therapies.
About this Event

On November 14 and 15, 2022, the National Cancer Policy Forum will host a public hybrid workshop that will examine the current challenges related to resistance to immune modulator therapies for cancer and discuss potential policy levers that could help to overcome these challenges.

To support preventing the infection and spread of the COVID-19 virus, and as an integral measure towards the safety and health of everyone in our buildings, the National Academies requires that all visitors to NASEM facilities be up-to-date on their vaccinations against COVID-19 per CDC guidance. Those with up-to-date vaccinations may choose to wear a mask in NASEM facilities.

Visitors must show their official COVID-19 Vaccination Record Card (or a digital photo of the card) before entering any National Academies building. For more details regarding access to NASEM facilities and expectations for visitors, please visit our operating status webpage.

Disclaimer: This registration information is being collected via Eventbrite. Eventbrite is not affiliated in any way with, or endorsed by, the National Academies of Sciences, Engineering, and Medicine, and your submission via the Eventbrite website is subject to Eventbrite’s privacy and terms of use.

Advertisement

Event Venue & Nearby Stays

NAS Building, 2101 Constitution Ave., NW, Washington, United States

Tickets

USD 0.00

Sharing is Caring: